With a revenue increase of 16.45% in the third quarter 2026, year on year to cumulative value of $288 million, Rigel Pharmaceuticals Inc's revenue per employee grew on a trailing twelve months basis to $ 1,656,397, this is below the company average.
Within the Healthcare sector Employees of 41 other companies have achieved higher revenue per employee. While Rigel Pharmaceuticals Inc's total ranking has deteriorated compared to the previous quarter from 208 to 492. Rigel Pharmaceuticals Inc has 174 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RIGL Revenue per Employee	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Revenue Change	16.45 %	-22.6 %	10.28 %	21.19 %	25.59 %
Sales per Employee (TTM) $	1,656,397	1,590,718	1,722,799	1,691,276	1,621,126
RIGL's Total Ranking	# 492	# 208	# 360	# 358	#
Seq. Revenue Change	2.78 %	33.81 %	-15.74 %	0.49 %	-31.69 %

RIGL Company Profile >> Back to RIGL Efficiency Comparisons >> Compare RIGL Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 29
Healthcare Sector	# 42
Overall Market	# 492

Revenue per Employee Statistics
High	Average	Low
$ 1,722,799	$ 679,030	$ 108,839
(Mar 31 2026)		(Mar 31 2017)

Financial Statements
Rigel Pharmaceuticals Inc's Revenue MRQ	$ 81 Millions	Visit RIGL's Income Statement
Rigel Pharmaceuticals Inc's Revenues TTM	$ 288 Millions	Visit RIGL's aggregate revenue growth
What are RIGL's Sales?		Visit RIGL's Sales by Segment

Other Ratios
Rigel Pharmaceuticals Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
RIGL's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for RIGL's Competitors
Revenue per Employee for RIGL's Suppliers
Revenue per Employee for RIGL's Customers

You may also want to know
RIGL's Sales Growth Rates	RIGL's Pe Price to earnings ratio	RIGL's Receivables Turnover Ratio	RIGL's Stock Quote
RIGL's Net Income Growth Rates	RIGL's Ps Price to Sales ratio	RIGL's Sales per Employee	RIGL's Asset Turnover Ratio
RIGL's Net Margin	RIGL's Pb Price to Book ratio	RIGL's Financial Strength Ratios	RIGL's Dividend Payout Ratio

Date modified: 2026-11-08T10:01:20+00:00

Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Sep 30 2026	Number of Employees Sep 30 2026
Kiniksa Pharmaceuticals International Plc	2,584,598.36	$ 945.963 Million	366
Aurinia Pharmaceuticals Inc	2,513,578.12	$ 321.738 Million	128
Zevra Therapeutics Inc	2,304,065.57	$ 140.548 Million	61
Nurix Therapeutics Inc	2,214,309.15	$ 701.936 Million	317
Exelixis Inc	2,176,862.25	$ 2,496.861 Million	1,147
Incyte Corporation	2,113,485.94	$ 6,010.754 Million	2,844
Alnylam Pharmaceuticals Inc	2,005,296.80	$ 5,013.242 Million	2,500
Neurocrine Biosciences Inc	1,850,850.00	$ 3,701.700 Million	2,000
Tarsus Pharmaceuticals Inc	1,843,791.89	$ 682.203 Million	370
Gilead Sciences Inc	1,822,823.53	$ 30,988.000 Million	17,000
Mirum Pharmaceuticals Inc	1,803,166.67	$ 670.778 Million	372
Eli Lilly And Company	1,729,240.00	$ 86,462.000 Million	50,000
Jazz Pharmaceuticals Plc	1,632,569.55	$ 4,718.126 Million	2,890
Krystal Biotech Inc	1,593,305.08	$ 470.025 Million	295
Madrigal Pharmaceuticals Inc	1,560,590.16	$ 1,427.940 Million	915
Bristol myers Squibb Company	1,539,476.92	$ 50,033.000 Million	32,500
Indivior Pharmaceuticals Inc	1,376,000.00	$ 1,376.000 Million	1,000
Biogen Inc	1,372,973.33	$ 10,297.300 Million	7,500
Supernus Pharmaceuticals inc	1,326,849.69	$ 865.106 Million	652
Corcept Therapeutics Inc	1,320,064.38	$ 963.647 Million	730
Travere Therapeutics Inc	1,309,927.57	$ 651.034 Million	497
Ptc Therapeutics inc	1,166,048.44	$ 1,155.554 Million	991
Abbvie Inc	1,158,140.35	$ 66,014.000 Million	57,000
Biomarin Pharmaceutical Inc	1,134,780.19	$ 3,655.127 Million	3,221
Bridgebio Pharma Inc	1,126,984.51	$ 945.540 Million	839
Arvinas Inc	1,119,105.69	$ 275.300 Million	246
Regeneron Pharmaceuticals Inc	1,096,443.87	$ 16,896.200 Million	15,410
Syndax Pharmaceuticals Inc	971,244.97	$ 289.431 Million	298
Ardelyx inc	957,505.11	$ 468.220 Million	489
Axsome Therapeutics Inc	935,424.86	$ 865.268 Million	925

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.